Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Sep, 29 2025
Dec, 9 2025
Oct, 15 2025
Oct, 27 2025
Oct, 3 2025